Novel approaches to improve recipient and allograft outcomes

Kidney transplantation was the focus of numerous publications in 2016. Key studies demonstrated a survival advantage of HLA-incompatible kidney transplantation and suggested that novel approaches such as co-stimulation blockade using belatacept and treatment of antibody-mediated rejection using a Cl esterase inhibitor might prove to be future game changers.